Toggle light / dark theme

Stimulating the growth of blood vessels in the brain through the use of fibroblast growth factor 1 (FGF1) may hold promise as a strategy for treating Parkinson’s disease, according to a white paper released by Zhittya Genesis Medicine (ZGM). Clinical trials testing this theory are being planned.

The white paper is titled “Parkinson’s Disease: Therapeutic Angiogenesis as a Disease Modifying, Breakthrough Therapy?”

It’s pretty difficult to believe it at this point, but there are still groups of Tesla critics who insist that Gigafactory 3 is not really fully operational. A central part of this thesis is the allegation that Gigafactory 3 does not have a stamping press, which means that Tesla’s China team is only assembling cars in the Shanghai-based factory using pre-stamped panels from Fremont.

A recently released video from Tesla China has just decimated these allegations in a subtle but definitive manner. The clip was short, less than 30 seconds long, but it showed a busy stamping press operating in Gigafactory 3. The video was released in China, and shared on Twitter by Tesla enthusiast @JayinShanghai.